Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin gets FDA approval of sNDA for Solosec
The supplemental adolescent approval enhances Solosec's strong position as the first and only single-dose oral prescription…
Quotient Sciences completes integration of drug substance into Translational Pharmaceutics platform
The newly enhanced drug development platform will help empower innovators with the fastest development timelines
Quality of antibodies improves for months after COVID vaccination: Study
The researchers at Washington University School of Medicine in the US assessed the antibody response to the Pfizer-BioNTech…
Analytical Development (ADL) Conclave 2022 | 11th March 2022
11th March 2022 | 1:30 PM - 6:30 PM IST | Virtual Conference
AstraZeneca receives EU approval for Saphnelo
The approval by the European Commission was based on results from the Saphnelo clinical development programme, including the Tulip…
Cambrian Biopharma announces licensing agreement to develop selective mTOR inhibitors
mTOR inhibitors prevent age-related physiologic decline and lengthen healthspan
EU to donate 29 million COVID vaccine doses to Africa
Germany will contribute 21 million vaccine doses, a government official said ahead of the meeting between leaders of the African…
Pfizer and Opko’s Ngenla injection gets marketing authorisation in EU
Ngenla provides pediatric patients, their caregivers and healthcare providers with a new treatment option for Growth Hormone…
Bangalore Bioinnovation Centre collaborates with Cytiva to provide bioprocessing training programmes
The programmes will support the start-up ecosystem, academia, new ventures and biopharmaceutical projects
Rovi seals 10-year Moderna deal extension to manufacture mRNA drugs
The deal includes new investment to expand capacity at Rovi’s plants, the company said without disclosing the amount of investment